Article info

Original research
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers

Authors

  1. Correspondence to Dr Nicola Valeri, Molecular Pathology, The Institute of Cancer Research, Sutton, United Kingdom; nicola.valeri{at}icr.ac.uk
View Full Text

Citation

Smyth EC, Vlachogiannis G, Hedayat S, et al
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers

Publication history

  • Received July 28, 2020
  • Revised October 14, 2020
  • Accepted October 15, 2020
  • First published November 16, 2020.
Online issue publication 
August 06, 2021

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.